Edgewise Therapeutics, Inc.
NASDAQ:EWTX · NASDAQ Global Select
+$1.11 today
Vol 1.92M · Avg 1.32M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+159.59%
Period High
$40.26
Period Low
$12.61
Latest
$36.81
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
uniQure N.V.
NASDAQ:QURE
$2.95B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.63B
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.53B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.20B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$2.08B
Nuvation Bio Inc.
NYSE:NUVB
$1.89B
Galapagos N.V.
GLPG
$1.84B
Mesoblast Limited
NASDAQ:MESO
$1.84B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.51B
Janux Therapeutics, Inc.
NASDAQ:JANX
$858.72M
What is the latest EWTX filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does EWTX have?
Intrinsic Alpha currently shows 20 recent filings for EWTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.